Simon Conway is a Senior Managing Director at FTI Consulting and is based in London. Dr. Conway is in the Life sciences practice in the Strategic Communications segment.
Dr. Conway joined FTI Consulting from Evolution Securities where he was the research analyst responsible for the biotech and small cap healthcare sector. Prior to that he spent several years on the buyside, including stints at Millennium Capital and Lehman Brothers as the analyst on global healthcare investment portfolios. Before that he was on the sellside as the European Biotech analyst at Bear Stearns.
Dr. Conway began his City Career at Williams de Broë as a healthcare analyst. Dr. Conway also has first-hand experience of the biotech industry having worked as a scientist at Peptide Therapeutics (Acambis).
By profession Dr. Conway is a Chemist who obtained his credentials at Imperial College, Cambridge University and Stanford University.
Dr. Conway's current clients include Verona Pharma, EGI, Circassia, GW Pharmaceuticals, Optos, Cyprotex, Lombard Medical Technologies, BTG, Vectura and BergenBio.
T: +44 20 3727 1106
London EC1A 4HD